VJHemOnc is committed to improving our service to you

ISA 2020 | Burning questions: ASCT in AL amyloidosis

VJHemOnc is committed to improving our service to you

Vaishali Sanchorawala

Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, discusses the burning questions in the use of autologous stem cell transplant (ASCT) in AL amyloidosis. The successful use of novel agents and data drawn from the ANDROMEDA trial (NCT03201965) is referenced as to why the utility of ASCT in AL amyloidosis may be questioned. However, Dr Sanchorawala does go on to explain how for a small patient population, ASCT is still a very useful tool. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter